Anti-PD-L1 antibodies
US-12570746-B2 · Mar 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
Wuxi Biologics Ireland Ltd — Human Necessities
Wuxi Biologics Ireland Ltd holds 77 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Wuxi Biologics Ireland Ltd |
| Technology | Human Necessities |
| Patents in slice | 77 |
| Recent patents in slice | 34 |
| First year | 2019 |
| Last year | 2026 |
Representative patents
Notable publications linking Wuxi Biologics Ireland Ltd to Human Necessities.
Anti-PD-L1 antibodies
US-12570746-B2 · Mar 10, 2026 · US
Anti-CD3epsilon antibodies
US-12485298-B2 · Dec 2, 2025 · US
Anti-CD3epsilon antibodies
US-12485298-B2 · Dec 2, 2025 · US
Anti-B7H3 antibody and Uses thereof
US-2025313633-A1 · Oct 9, 2025 · US
Recent filings
Latest patents from Wuxi Biologics Ireland Ltd in Human Necessities.
Anti-PD-L1 antibodies
US-12570746-B2 · Mar 10, 2026 · US
Anti-PD-L1 antibodies
US-12570746-B2 · Mar 10, 2026 · US
Anti-CD3epsilon antibodies
US-12485298-B2 · Dec 2, 2025 · US
Anti-CD3epsilon antibodies
US-12485298-B2 · Dec 2, 2025 · US
Anti-B7H3 antibody and Uses thereof
US-2025313633-A1 · Oct 9, 2025 · US
Related pages
Navigate to parent entity pages.